Elevated PXR expression was significantly associated with advanced disease stage and increased tumor proliferative capacity, assessed by Ki-67 labelling index, in uterine carcinosarcoma, leiomyosarcoma, and endometrial stromal sarcoma [48]. The gene discussed is MKI67; the disease is endometrioid stromal sarcoma.